Analyst IMS Investment Management Services’s Novo Nordisk NVO Stock Holding History

Analyst IMS Investment Management Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7M	Sell	410,770 -900	-0.2%	-$38.7K	0.46%	26
2026 Q1	$15.1M	Buy	411,670 +405,600	+6,682%	+$19.2M	0.46%	26
2025 Q4	$309K	Buy	+6,070	New	+$310K	0.01%	113
2024 Q4	–	Sell	-4,004	Closed	-$477K	–	132
2024 Q3	$477K	Hold	4,004	–	–	0.02%	109
2024 Q2	$571K	Hold	4,004	–	–	0.02%	95
2024 Q1	$515K	Buy	+4,004	New	+$477K	0.02%	90

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Analyst IMS Investment Management Services's NVO Position: Q2 2026 in Review

Analyst IMS Investment Management Services reduced its Novo Nordisk (NVO) stake by 0.22% in Q2 2026, selling an estimated $38.7K and leaving 410,770 shares worth $19.7M. The position accounts for 0.46% of the portfolio, ranked #26.

Analyst IMS Investment Management Services first reported a position in NVO in Q1 2024 and has held it in 6 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Analyst IMS Investment Management Services held 410,770 shares of Novo Nordisk worth $19.7M as of Q2 2026.
Analyst IMS Investment Management Services sold 900 Novo Nordisk shares in Q2 2026, an estimated $38.7K.
Novo Nordisk made up 0.46% of Analyst IMS Investment Management Services's portfolio in Q2 2026, its #26 holding.
Analyst IMS Investment Management Services first reported a position in Novo Nordisk in Q1 2024 and has held it in 6 quarters since.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.